%0 Journal Article
%A Reck, M
%A Ciuleanu, T-E
%A Cobo, M
%A Schenker, M
%A Zurawski, B
%A Menezes, J
%A Richardet, E
%A Bennouna, J
%A Felip, E
%A Juan-Vidal, O
%A Alexandru, A
%A Sakai, H
%A Lingua, A
%A Reyes, F
%A Souquet, P-J
%A De Marchi, P
%A Martin, C
%A Pérol, M
%A Scherpereel, A
%A Lu, S
%A Paz-Ares, L
%A Carbone, D P
%A Memaj, A
%A Marimuthu, S
%A Zhang, X
%A Tran, P
%A John, T
%T Corrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273].
%D 2021
%U https://hdl.handle.net/10668/24575
%~